Trial
NCT02378922
Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
AIDS-Related Hodgkin Lymphoma
Intervention
Gene-Modified HIV-Protected Hematopoietic Stem Cells
Why stopped
Administratively closed prior to subject enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-27